1. Home
  2. YMAB vs JOUT Comparison

YMAB vs JOUT Comparison

Compare YMAB & JOUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • JOUT
  • Stock Information
  • Founded
  • YMAB 2015
  • JOUT 1970
  • Country
  • YMAB United States
  • JOUT United States
  • Employees
  • YMAB N/A
  • JOUT N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • JOUT Recreational Games/Products/Toys
  • Sector
  • YMAB Health Care
  • JOUT Consumer Discretionary
  • Exchange
  • YMAB Nasdaq
  • JOUT Nasdaq
  • Market Cap
  • YMAB 386.7M
  • JOUT 421.8M
  • IPO Year
  • YMAB 2018
  • JOUT N/A
  • Fundamental
  • Price
  • YMAB $8.61
  • JOUT $41.00
  • Analyst Decision
  • YMAB Buy
  • JOUT
  • Analyst Count
  • YMAB 10
  • JOUT 0
  • Target Price
  • YMAB $13.91
  • JOUT N/A
  • AVG Volume (30 Days)
  • YMAB 874.6K
  • JOUT 46.0K
  • Earning Date
  • YMAB 11-07-2025
  • JOUT 08-01-2025
  • Dividend Yield
  • YMAB N/A
  • JOUT 3.22%
  • EPS Growth
  • YMAB N/A
  • JOUT N/A
  • EPS
  • YMAB N/A
  • JOUT N/A
  • Revenue
  • YMAB $85,385,000.00
  • JOUT $562,527,000.00
  • Revenue This Year
  • YMAB N/A
  • JOUT N/A
  • Revenue Next Year
  • YMAB $13.97
  • JOUT $7.39
  • P/E Ratio
  • YMAB N/A
  • JOUT N/A
  • Revenue Growth
  • YMAB N/A
  • JOUT N/A
  • 52 Week Low
  • YMAB $3.55
  • JOUT $21.33
  • 52 Week High
  • YMAB $16.11
  • JOUT $42.88
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 81.21
  • JOUT 59.70
  • Support Level
  • YMAB $8.50
  • JOUT $39.96
  • Resistance Level
  • YMAB $8.56
  • JOUT $41.20
  • Average True Range (ATR)
  • YMAB 0.02
  • JOUT 1.40
  • MACD
  • YMAB -0.12
  • JOUT -0.24
  • Stochastic Oscillator
  • YMAB 100.00
  • JOUT 71.43

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About JOUT Johnson Outdoors Inc.

Johnson Outdoors Inc is a manufacturer and marketer of branded seasonal, outdoor recreation products used for fishing from a boat, diving, paddling, hiking and camping. The company has four operating segment: Fishing, Camping, Watercraft Recreation, and Diving. It generates maximum revenue from the Fishing segment which produces and markets products under different brands such as Minn Kota electric motors for quiet trolling or primary propulsion, marine battery chargers and shallow water anchors; Humminbird sonar and GPS equipment for fish finding, navigation and marine cartography; and Cannon downriggers for controlled-depth fishing. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe, Canada, and other regions.

Share on Social Networks: